Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,301,045
-
Share change
-
+903,262
-
Total reported value
-
$211,111,390
-
Put/Call ratio
-
168%
-
Price per share
-
$7.46
-
Number of holders
-
102
-
Value change
-
-$214,788,430
-
Number of buys
-
65
-
Number of sells
-
77
Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q3 2015
As of 30 Sep 2015,
TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,301,045 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, FMR LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, BB BIOTECH AG, GREAT POINT PARTNERS LLC, BlackRock Institutional Trust Company, N.A., GRANAHAN INVESTMENT MANAGEMENT INC/MA, and Sectoral Asset Management Inc.
This page lists
102
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.